Accord Healthcare recalls

Accord Healthcare has 106 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 2 Sep 2026. 25 are still ongoing. 14 were reported in the last 12 months. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls106since 2017

Last 12 months14reported

Class I22% of total

Ongoing25latest 2 Sep 2026

Recalls per month, last 24 months

click a bar for that month

3Nov '24 1 0 0Feb 0 0 4May 0 7 0Aug 0 1 0Nov 0 0 0Feb 0 0 0May 0 1 0Aug 12 0

Severity split

Class I 2 2%Class II 101 95%Class III 3 3%

Why accord healthcare is recalled

Product types

Brands

By year

20261312%
20251211%
202466%
20237268%
202111%
201811%
201711%

Ongoing accord healthcare recalls

25 active

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide

All accord healthcare recalls, newest first

106 total

Reported	Class	Recall	Company	Reason	Where
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
8 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
15 Oct 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
23 Jul 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
11 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) recalledLevothyroxine Sodium	Accord Healthcare	Potency & Assay	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets 30 mg recalled by Accord HealthcareCinacalcet	Accord Healthcare	Nitrosamine Impurity	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets, 60 mg recalled by Accord HealthcareCinacalcet	Accord Healthcare	Nitrosamine Impurity	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets, 90 mg recalled by Accord HealthcareCinacalcet	Accord Healthcare	Nitrosamine Impurity	Nationwide
23 Oct 2024Drug	CLASS II	Cisplatin Injection, 100mg/ (1mg/mL) recalled by Accord HealthcareCisplatin	Accord Healthcare	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.